63 related articles for article (PubMed ID: 22617167)
1. Gut-derived lipopolysaccharide promotes T-cell-mediated hepatitis in mice through Toll-like receptor 4.
Lin Y; Yu LX; Yan HX; Yang W; Tang L; Zhang HL; Liu Q; Zou SS; He YQ; Wang C; Wu MC; Wang HY
Cancer Prev Res (Phila); 2012 Sep; 5(9):1090-102. PubMed ID: 22617167
[TBL] [Abstract][Full Text] [Related]
2. Effects of gut-derived endotoxin on anxiety-like and repetitive behaviors in male and female mice.
Fields CT; Chassaing B; Castillo-Ruiz A; Osan R; Gewirtz AT; de Vries GJ
Biol Sex Differ; 2018 Jan; 9(1):7. PubMed ID: 29351816
[TBL] [Abstract][Full Text] [Related]
3. Gut microbiome-mediated monocytes promote liver metastasis.
Zhang W; Ling J; Xu B; Wang J; Chen Z; Li G
Int Immunopharmacol; 2024 May; 133():111877. PubMed ID: 38608440
[TBL] [Abstract][Full Text] [Related]
4. Lipopolysaccharide associated with β-2,6 fructan mediates TLR4-dependent immunomodulatory activity in vitro.
Young ID; Nepogodiev SA; Black IM; Le Gall G; Wittmann A; Latousakis D; Visnapuu T; Azadi P; Field RA; Juge N; Kawasaki N
Carbohydr Polym; 2022 Feb; 277():118606. PubMed ID: 34893207
[TBL] [Abstract][Full Text] [Related]
5. Resistance to lipopolysaccharide-induced preterm delivery mediated by regulatory T cell function in mice.
Bizargity P; Del Rio R; Phillippe M; Teuscher C; Bonney EA
Biol Reprod; 2009 May; 80(5):874-81. PubMed ID: 19144956
[TBL] [Abstract][Full Text] [Related]
6. Exposure to bacterial products lipopolysaccharide and flagellin and hepatocellular carcinoma: a nested case-control study.
Fedirko V; Tran HQ; Gewirtz AT; Stepien M; Trichopoulou A; Aleksandrova K; Olsen A; Tjønneland A; Overvad K; Carbonnel F; Boutron-Ruault MC; Severi G; Kühn T; Kaaks R; Boeing H; Bamia C; Lagiou P; Grioni S; Panico S; Palli D; Tumino R; Naccarati A; Peeters PH; Bueno-de-Mesquita HB; Weiderpass E; Castaño JM; Barricarte A; Sánchez MJ; Dorronsoro M; Quirós JR; Agudo A; Sjöberg K; Ohlsson B; Hemmingsson O; Werner M; Bradbury KE; Khaw KT; Wareham N; Tsilidis KK; Aune D; Scalbert A; Romieu I; Riboli E; Jenab M
BMC Med; 2017 Apr; 15(1):72. PubMed ID: 28372583
[TBL] [Abstract][Full Text] [Related]
7. Predicting mucositis risk associated with cytotoxic cancer treatment regimens: rationale, complexity, and challenges.
Bachour PC; Sonis ST
Curr Opin Support Palliat Care; 2018 Jun; 12(2):198-210. PubMed ID: 29547492
[TBL] [Abstract][Full Text] [Related]
8. Toll like receptor 4 facilitates invasion and migration as a cancer stem cell marker in hepatocellular carcinoma.
Liu WT; Jing YY; Yu GF; Han ZP; Yu DD; Fan QM; Ye F; Li R; Gao L; Zhao QD; Wu MC; Wei LX
Cancer Lett; 2015 Mar; 358(2):136-143. PubMed ID: 25511737
[TBL] [Abstract][Full Text] [Related]
9. Toll-like receptor 4 and hepatitis B infection: molecular mechanisms and pathogenesis.
Zare-Bidaki M; Tsukiyama-Kohara K; Arababadi MK
Viral Immunol; 2014 Sep; 27(7):321-6. PubMed ID: 25014492
[TBL] [Abstract][Full Text] [Related]
10. Role of toll-like receptors in immune activation and tolerance in the liver.
Nakamoto N; Kanai T
Front Immunol; 2014; 5():221. PubMed ID: 24904576
[TBL] [Abstract][Full Text] [Related]
11. Can Toll-Like Receptor (TLR) 2 be considered as a new target for immunotherapy against hepatitis B infection?
Bagheri V; Askari A; Arababadi MK; Kennedy D
Hum Immunol; 2014 Jun; 75(6):549-54. PubMed ID: 24530748
[TBL] [Abstract][Full Text] [Related]
12. TAK-242 can be the potential agents for preventing invasion and metastasis of hepatocellular carcinoma.
Yu P; Cheng X; Du Y; Huang L; Dong R
Med Hypotheses; 2013 Oct; 81(4):653-5. PubMed ID: 23910073
[TBL] [Abstract][Full Text] [Related]
13. Lipopolysaccharide-induced toll-like receptor 4 signaling in cancer cells promotes cell survival and proliferation in hepatocellular carcinoma.
Wang L; Zhu R; Huang Z; Li H; Zhu H
Dig Dis Sci; 2013 Aug; 58(8):2223-36. PubMed ID: 23828139
[TBL] [Abstract][Full Text] [Related]
14. Targeting gut flora to prevent progression of hepatocellular carcinoma.
Darnaud M; Faivre J; Moniaux N
J Hepatol; 2013 Feb; 58(2):385-7. PubMed ID: 22940407
[TBL] [Abstract][Full Text] [Related]
15. RNA m
Meng S; Jiangtao B; Haisong W; Mei L; Long Z; Shanfeng L
Front Immunol; 2024; 15():1362159. PubMed ID: 38807595
[TBL] [Abstract][Full Text] [Related]
16. Berberine alleviates concanavalin A-induced autoimmune hepatitis in mice by modulating the gut microbiota.
Yang H; Liu Q; Liu H; Kang X; Tian H; Kang Y; Li L; Yang X; Ren P; Kuang X; Wang X; Guo L; Tong M; Ma J; Fan W
Hepatol Commun; 2024 Apr; 8(4):. PubMed ID: 38466881
[TBL] [Abstract][Full Text] [Related]
17. The Role of TLR4 in the Immunotherapy of Hepatocellular Carcinoma: Can We Teach an Old Dog New Tricks?
Papadakos SP; Arvanitakis K; Stergiou IE; Lekakis V; Davakis S; Christodoulou MI; Germanidis G; Theocharis S
Cancers (Basel); 2023 May; 15(10):. PubMed ID: 37345131
[TBL] [Abstract][Full Text] [Related]
18. Crosstalk between liver macrophages and gut microbiota: An important component of inflammation-associated liver diseases.
Zhou Z; Pan X; Li L
Front Cell Dev Biol; 2022; 10():1070208. PubMed ID: 36483677
[TBL] [Abstract][Full Text] [Related]
19. Gut Microbiota Regulation of AHR Signaling in Liver Disease.
Wang B; Zhou Z; Li L
Biomolecules; 2022 Sep; 12(9):. PubMed ID: 36139083
[TBL] [Abstract][Full Text] [Related]
20. Relationship between Intestinal Microflora and Hepatocellular Cancer Based on Gut-Liver Axis Theory.
Li S; Han W; He Q; Zhang W; Zhang Y
Contrast Media Mol Imaging; 2022; 2022():6533628. PubMed ID: 35965618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
